Dolutegravir pharmacokinetics in pregnant and postpartum women living with HIV-Reference-Cited by-同舟云学术

Dolutegravir pharmacokinetics in pregnant and postpartum women living with HIV

Published:2018-03-27 Issue:6 Volume:32 Page:729-737
ISSN:0269-9370
Container-title:AIDS
language:en
Short-container-title:

Author:

Mulligan Nikki,Best Brookie M.,Wang Jiajia,Capparelli Edmund V.,Stek Alice,Barr Emily,Buschur Shelley L.,Acosta Edward P.,Smith Elizabeth,Chakhtoura Nahida,Burchett Sandra,Mirochnick Mark

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Infectious Diseases,Immunology,Immunology and Allergy

Reference28 articles.

1. Pharmacokinetic changes during pregnancy and their clinical relevance;Loebstein;Clin Pharmacokinet,1997

2. Reduced lopinavir exposure during pregnancy;Stek;AIDS,2006

3. Pharmacokinetics of saquinavir plus low-dose ritonavir in human immunodeficiency virus-infected pregnant women;Acosta;Antimicrob Agents Chemother,2004

4. Pharmacokinetics of once versus twice daily darunavir in pregnant HIV-infected women;Stek;J Acquir Immune Defic Syndr,2015

5. Etravirine pharmacokinetics in HIV-infected pregnant women;Mulligan;Front Pharmacol,2016

Cited by 77 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Enhancing Precision Drug Therapy and build pharmacokinetic model in Pregnant Women: PBPK Modeling of Antiviral drugs;2024-07-22

2. Breakthrough HIV viraemia on bictegravir/emtricitabine/tenofovir alafenamide in the third trimester of pregnancy;Journal of Antimicrobial Chemotherapy;2024-07-10

3. Pharmacogenetics of Efavirenz Exposure in Cervicovaginal Fluid during Pregnancy and Postpartum;Clinical Pharmacology & Therapeutics;2024-06-10

4. Pharmacokinetic and toxicological considerations affecting antiretroviral drug dosing in pregnant women;Expert Opinion on Drug Metabolism & Toxicology;2024-05-14

5. Long-Acting Injectable Cabotegravir and Rilpivirine in a Pregnant Woman Living With Human Immunodeficiency Virus;Clinical Infectious Diseases;2024-05-03